Health Care
Commentary
The real story behind Trump’s GLP-1 price cut: Markets still rule
President Donald Trump just announced deals with drugmakers Eli Lilly and Novo Nordisk that will yield lower prices for GLP-1 weight-loss drugs dispensed through Medicare and Medicaid. Both firms have also agreed to sell the drugs at lower prices on Trump’s yet-to-be-developed online marketplace for prescription drugs, TrumpRx. Lilly and ...
Commentary
Why reforming PBMs is the key to lowering drug costs
If lawmakers want to make pharmaceuticals more affordable, they should look past populist policies like price controls that will only make matters worse and set their sights on reforming the Pharmacy Benefit Manager market. PBMs manage the drug benefits for insurers and negotiate discounts with drug manufacturers. You probably use ...
Commentary
GAO Provides Yet More Evidence for Why Enhanced Obamacare Subsidies Must Expire
Defrauding the government through Obamacare’s insurance exchanges is shockingly easy, per a new government report. The study found that federal insurance subsidies were granted for 90 percent of the fake exchange accounts set up as part of a Government Accountability Office investigation — at a cost of more than $10,000 ...
Commentary
Despite Dems’ protests, affordable health plans are about to multiply
Obamacare premiums are climbing yet again during open enrollment. But there’s also some good news for cost-conscious shoppers ― a new way to secure affordable coverage without forgoing access to care. This year, many people can buy low-cost “catastrophic” health plans for the very first time. Combine one of these ...
Commentary
How Competition Drives Healthcare Innovation & Affordability
Making healthcare more affordable requires reforms that strengthen competitive markets, as I outlined in a recent Pacific Research Institute1 paper. Unfortunately, as we’re seeing in California and elsewhere, the trend in government is away from competition and toward fewer choices, hurting patients and increasing costs. When applied to other industries, ...
Blog
How did the US become the world’s center of pharmaceutical innovation?
What kinds of policies helped the US surpass Great Britain to become the world’s center of pharmaceutical innovation? I think it was a combination of shrewd reforms on the part of the United States, and self-destructive reforms on the part of Europe and other developed nations. In the 1970s, Europe ...
Commentary
Trade Policy Is The Right Way To Fight Foreign Freeloading
Last week, the United States and the United Kingdom announced a trade deal that will require Britain’s National Health Service to pay more for novel prescription drugs in exchange for a reprieve of at least three years from tariffs on its pharmaceutical exports. It’s a perfect example of how the ...
Commentary
‘Soak the Rich’ Won’t Rescue Calif. Healthcare
A group of unions in California has proposed a new plan for paying for healthcare — soak the rich. That’s the idea behind the Billionaire Tax Act, a 2026 ballot initiative that would impose a 5% tax on the state’s billionaires in order to raise money for healthcare programs and ...
Health Care
Sally Pipes – On the Health Care Debate in Washington
This week, PRI President, CEO and Thomas W. Smith Fellow in Health Care Policy Sally Pipes is back to discuss the debate over extending the expanded Obamacare subsidies that was at the heart of the recent government shutdown. She also discusses the market-based reforms that conservatives in Congress should be ...
Commentary
Competition, not price controls, just slashed GLP-1 prices
Novo Nordisk just announced price cuts for Ozempic and Wegovy, whose list prices as recently as last year were around $1,000 a month. Patients buying directly from the manufacturer will be able to pay as little as $349 for a monthly dose of these medicines. The company has also dropped ...
The real story behind Trump’s GLP-1 price cut: Markets still rule
President Donald Trump just announced deals with drugmakers Eli Lilly and Novo Nordisk that will yield lower prices for GLP-1 weight-loss drugs dispensed through Medicare and Medicaid. Both firms have also agreed to sell the drugs at lower prices on Trump’s yet-to-be-developed online marketplace for prescription drugs, TrumpRx. Lilly and ...
Why reforming PBMs is the key to lowering drug costs
If lawmakers want to make pharmaceuticals more affordable, they should look past populist policies like price controls that will only make matters worse and set their sights on reforming the Pharmacy Benefit Manager market. PBMs manage the drug benefits for insurers and negotiate discounts with drug manufacturers. You probably use ...
GAO Provides Yet More Evidence for Why Enhanced Obamacare Subsidies Must Expire
Defrauding the government through Obamacare’s insurance exchanges is shockingly easy, per a new government report. The study found that federal insurance subsidies were granted for 90 percent of the fake exchange accounts set up as part of a Government Accountability Office investigation — at a cost of more than $10,000 ...
Despite Dems’ protests, affordable health plans are about to multiply
Obamacare premiums are climbing yet again during open enrollment. But there’s also some good news for cost-conscious shoppers ― a new way to secure affordable coverage without forgoing access to care. This year, many people can buy low-cost “catastrophic” health plans for the very first time. Combine one of these ...
How Competition Drives Healthcare Innovation & Affordability
Making healthcare more affordable requires reforms that strengthen competitive markets, as I outlined in a recent Pacific Research Institute1 paper. Unfortunately, as we’re seeing in California and elsewhere, the trend in government is away from competition and toward fewer choices, hurting patients and increasing costs. When applied to other industries, ...
How did the US become the world’s center of pharmaceutical innovation?
What kinds of policies helped the US surpass Great Britain to become the world’s center of pharmaceutical innovation? I think it was a combination of shrewd reforms on the part of the United States, and self-destructive reforms on the part of Europe and other developed nations. In the 1970s, Europe ...
Trade Policy Is The Right Way To Fight Foreign Freeloading
Last week, the United States and the United Kingdom announced a trade deal that will require Britain’s National Health Service to pay more for novel prescription drugs in exchange for a reprieve of at least three years from tariffs on its pharmaceutical exports. It’s a perfect example of how the ...
‘Soak the Rich’ Won’t Rescue Calif. Healthcare
A group of unions in California has proposed a new plan for paying for healthcare — soak the rich. That’s the idea behind the Billionaire Tax Act, a 2026 ballot initiative that would impose a 5% tax on the state’s billionaires in order to raise money for healthcare programs and ...
Sally Pipes – On the Health Care Debate in Washington
This week, PRI President, CEO and Thomas W. Smith Fellow in Health Care Policy Sally Pipes is back to discuss the debate over extending the expanded Obamacare subsidies that was at the heart of the recent government shutdown. She also discusses the market-based reforms that conservatives in Congress should be ...
Competition, not price controls, just slashed GLP-1 prices
Novo Nordisk just announced price cuts for Ozempic and Wegovy, whose list prices as recently as last year were around $1,000 a month. Patients buying directly from the manufacturer will be able to pay as little as $349 for a monthly dose of these medicines. The company has also dropped ...
